Skip to main content

Bedside Hemodynamic Assessment: An Echocardiography Guide for the ICU

 

Bedside Hemodynamic Assessment: An Echocardiography Guide for the ICU


Bedside echocardiography has become a cornerstone of modern ICU practice. Beyond simple assessment of left ventricular ejection fraction, focused echocardiography allows real-time evaluation of pressures, congestion, systemic flow, and shock physiology. A structured approach transforms echo from a descriptive tool into a true hemodynamic monitor.

---

1. Role of Echocardiography in ICU Hemodynamics


Critically ill patients often have complex, rapidly changing physiology. Invasive monitoring is not always available or reliable. Bedside echocardiography provides:


• Non-invasive, repeatable hemodynamic assessment

• Immediate correlation with clinical status

• Guidance for fluids, inotropes, and vasopressors

• Etiologic diagnosis of shock


A practical framework divides assessment into two domains:


1. Pressures and congestion



2. Systemic flow and shock state





---


2. Assessing Pressures and Venous Congestion


A. Inferior Vena Cava (IVC)


IVC assessment is the entry point for venous congestion:


• IVC diameter

• Respiratory variation (collapsibility/distensibility)


Limitations: • Mechanical ventilation

• Elevated intra-abdominal pressure

• RV dysfunction


Hence, IVC alone is insufficient and should be integrated into a multiparametric approach.



---


B. Venous Excess Ultrasound (VExUS) Score


The VExUS score quantifies systemic venous congestion by combining IVC size with Doppler patterns of abdominal veins.


Components


1. IVC diameter



2. Hepatic vein Doppler



3. Portal vein Doppler



4. Renal vein Doppler




Interpretation • Normal venous flow → minimal congestion

• Pulsatile or reversed flow → severe congestion


Clinical relevance: • Detects harmful venous congestion even when BP and CI appear acceptable

• Predicts acute kidney injury

• Guides decongestive therapy



---


C. Screening for Pulmonary Hypertension (PH)


Echo markers suggesting PH include:


• Tricuspid regurgitation (TR) peak velocity

– TR velocity > 3.4 m/s → high probability of PH


• RV enlargement or dysfunction

• Interventricular septal flattening


PH is common in ICU patients with ARDS, PE, sepsis, and left-sided heart disease.



---


D. Differentiating Pre- vs Post-Capillary PH


Echo helps distinguish the mechanism of PH, which directly impacts management.


Pre-capillary PH • Normal left atrial pressure

• Elevated pulmonary vascular resistance (PVR)

• RV pressure overload


Post-capillary PH • Elevated left atrial pressure

• LV diastolic dysfunction

• Mitral valve disease


Key echo tools: • E/e′ ratio

• Left atrial volume index (LAVI)

• TR velocity

• ePLAR (E/e′ divided by TR velocity)


This distinction prevents inappropriate therapies (e.g., vasodilators in left-sided failure).



---


3. Assessing Left Atrial Pressure and Diastolic Function


Elevated left atrial pressure (LAP) is a major driver of pulmonary edema and hypoxemia in ICU patients.


Echo Parameters Used


• E/e′ ratio

• LAVI

• TR velocity


Integrated interpretation increases accuracy, especially in: • Sepsis

• HFpEF

• Post-cardiac surgery patients


Diastolic dysfunction should always be considered when: • Pulmonary edema is disproportionate

• LV systolic function is preserved



---


4. Assessing Systemic Flow


Cardiac Output and Cardiac Index


Stroke volume and cardiac output are calculated using:


• LVOT diameter

• LVOT VTI


Cardiac Index (CI): • CI < 2.2 L/min/m² → inadequate systemic flow


Echo allows trend monitoring after: • Fluids

• Inotropes

• Vasopressors



---


5. Hemodynamic Classification of Shock Using Echocardiography


Echo enables physiologic classification of shock rather than relying on blood pressure alone.


A. Cardiogenic Shock


Echo findings • Reduced LV and/or RV function

• Low CI (< 2.2 L/min/m²)

• Elevated filling pressures

• Increased SVR


Management implication • Inotropes

• Mechanical circulatory support (selected cases)

• Avoid excessive fluids



---


B. Hypovolemic Shock


Echo findings • Small, hyperdynamic ventricles

• Low CI

• Collapsible IVC

• High SVR


Management implication • Fluid resuscitation

• Identify source of volume loss



---


C. Distributive Shock (e.g., Septic Shock)


Echo findings • Normal or high CI (> 2.2 L/min/m²)

• Low SVR

• Variable ventricular function


Management implication • Vasopressors

• Judicious fluids

• Inotropes if myocardial depression present



---


6. Integrating Congestion and Flow: The Key ICU Concept


Optimal hemodynamics require balancing: • Forward flow (cardiac output)

• Backward pressure (venous congestion)


A patient may have: • Adequate CI but severe venous congestion

• Low CI with minimal congestion


Echo helps avoid two common ICU errors: • Over-resuscitation with fluids

• Late recognition of cardiogenic components in shock



---


7. Practical Bedside Algorithm


1. Assess IVC and VExUS → congestion



2. Evaluate LV and RV function



3. Estimate LAP and diastolic function



4. Calculate CI and systemic flow



5. Classify shock physiologically



6. Tailor therapy and reassess dynamically





---


8. Key Take-Home Messages


• Bedside echocardiography is a hemodynamic monitoring tool, not just an imaging modality

• Venous congestion is as important as low cardiac output

• Shock should be classified physiologically, not by blood pressure alone

• Integration of Doppler, chamber assessment, and flow measurements improves outcomes

• Repeated focused exams guide real-time ICU decision-making



---


Bedside echocardiography transforms ICU care from reactive to physiology-guided management, enabling precise, individualized hemodynamic therapy.



Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.